CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GlaxoSmithKline Biological's Live Attenuated Measles Mumps Rubella Varicella Vaccine (PriorixTetra™) When Co-administered With Conjugated Meningococcal C Vaccine (Meningitec®, Nuron Biotechs' Vaccine) in Healthy Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01506193
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:50.377188+00:00
Published At: 2017-01-09T00:00:00+00:00
Record Updated At: 2018-08-17
Results Posted At: 2017-01-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rubella", "Varicella", "Measles", "Mumps"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-17"
protocolSection.identificationModule.nctId: "NCT01506193"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety Study of GlaxoSmithKline Biological\u0027s Live Attenuated Measles Mumps Rubella Varicella Vaccine (PriorixTetra\u2122) When Co-administered With Conjugated Meningococcal C Vaccine (Meningitec\u00ae, Nuron Biotechs\u0027 Vaccine) in Healthy Children"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-01-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.